1-236178568-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003272.4(GPR137B):c.619G>A(p.Val207Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000093 in 1,612,784 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003272.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR137B | NM_003272.4 | c.619G>A | p.Val207Ile | missense_variant | 3/7 | ENST00000366592.8 | NP_003263.1 | |
GPR137B | XM_017002209.3 | c.619G>A | p.Val207Ile | missense_variant | 3/7 | XP_016857698.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR137B | ENST00000366592.8 | c.619G>A | p.Val207Ile | missense_variant | 3/7 | 1 | NM_003272.4 | ENSP00000355551.3 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151910Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000171 AC: 43AN: 251470Hom.: 1 AF XY: 0.000287 AC XY: 39AN XY: 135910
GnomAD4 exome AF: 0.0000986 AC: 144AN: 1460874Hom.: 2 Cov.: 31 AF XY: 0.000147 AC XY: 107AN XY: 726766
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151910Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74170
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.619G>A (p.V207I) alteration is located in exon 3 (coding exon 3) of the GPR137B gene. This alteration results from a G to A substitution at nucleotide position 619, causing the valine (V) at amino acid position 207 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at